Australian Clinical Labs
ACL.AX
#6844
Rank
ยฃ0.35 B
Marketcap
ยฃ1.76
Share price
-0.58%
Change (1 day)
31.02%
Change (1 year)

Revenue for Australian Clinical Labs (ACL.AX)

Revenue in 2023: ยฃ0.36 Billion

According to Australian Clinical Labs's latest financial reports the company's current revenue (TTM ) is ยฃ0.36 Billion. In 2023 the company made a revenue of ยฃ0.36 Billion a decrease over the revenue in the year 2022 that were of ยฃ0.53 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Australian Clinical Labs from 2021 to 2023

Annual revenue

Year Revenue Change
2023ยฃ0.36 B-32.69%
2022ยฃ0.53 B41.26%
2021ยฃ0.37 B